Objectives: Malassezia species are common, clinically relevant, and lipid‐dependent yeasts of humans. They are also the leading causes of the dandruff problem of humans, and the azoles are used primarily in their topical and systemic treatment. Resistance to azoles is an emerging problem among Malassezia sp., which indicates the need of new drug assessments that will be effective against dandruff and limit the use of azoles and other agents in treatment. Among them, the efficacy of various combinations of piroctone olamine and climbazole against Malassezia sp. is highly important. Here, we assessed the efficacies of various piroctone olamine and climbazole formulations against Malassezia sp. in comparison with ketoconazole.Methods: A total of nine formulations were included in the study, where each formulation was prepared from different concentrations of piroctone olamine and climbazole and both. All formulations contained the same ingredients as water, surfactants, hair conditioning agents, and preservatives. Malassezia furfur CBS1878, Malassezia globosa CBS7874, and Malassezia sympodialis CBS9570 were tested for antifungal susceptibility of each formulation by agar diffusion method. Sizes of the inhibition zones were compared with standard medical shampoo containing 2% ketoconazole, and the data were analyzed by Dunnett's multiple‐comparison test.Results: For all Malassezia sp. strains, climbazole 0.5% and piroctone olamine/climbazole (0.1%/0.1% and 0.1%/0.5%) combinations were found to have the same effect as the medical shampoo containing 2% ketoconazole. Piroctone olamine/climbazole 1.0%/0.1% formulation showed the same efficacy as 2% ketoconazole on M. furfur and M. sympodialis, while 0.1%/0.5% formulation to only M. furfur. For M. globosa, none of the formulations tested were as effective as ketoconazole.Conclusion: The species distribution of Malassezia sp. varies depending on the anatomical location on the host. According to the results of this study, climbazole and piroctone olamine combinations seem to be promising options against the dandruff problem with their high antifungal/anti dandruff efficacy.
Introduction: Phoenix Dactylifera L (PDL) is a fruit containing a rich source of nutrients and bioactive molecules. Doxorubicin is a widely used agent, especially in the treatment of solid cancers. However, cardiotoxicity is one of its most challenging side effects. The present study aimed to investigate the preventive effect of PDL extract against doxorubicin-induced cardiotoxicity. Patients and Methods: A total of 24 albino Wistar rats were divided into four equal groups. Phoenix Dactylifera L (PDLG) and Phoenix Dactylifera L + doxorubicin (PDXG) groups were strictly fed PDL for two weeks. The control group (CG) and the doxorubicin group (DOXG) were fed a standard diet. During this time, 5 mg/kg of doxorubicin was injected intraperitoneally to DOXG and PDXG once a day. Results: Administration of doxorubicin to the DOXG significantly increased tissue oxidative stress parameters and caused the cardiac biomarker troponin-I (TP-I) to be released into the circulation; on the contrary, the levels of potent antioxidants such as total glutathione, superoxide dismutase, and catalase significantly decreased in DOXG compared to the other three groups. However, feeding purely with PDL decreased oxidative stress parameters and TP-I levels in PDXG animals, despite exposure to doxorubicin. Additionally, an excessive decrease of tissue antioxidants was prevented when compared to the DOXG. Histopathological damage signs, such as necrosis and hemorrhage, were severe in the DOXG. However, in the PDXG animals, feeding with PDL provided the integrity of the heart tissue structure. Conclusion: PDL was able to improve the cardiotoxic consequences of doxorubicin biochemically and histopathologically, possibly due to its antioxidant properties.
1 April 2026 in Clinical, Cosmetic and Investigational Dermatology
Myrtus communis L. (M. communis) is an aromatic evergreen perennial plant, which is native to Mediterranean region and West Asia, has been used in numerous diseases including some disorders of skin in traditional medicine. This study investigates the modulatory effects of M. communis leaf extract on IL-1α and VEGF gene expressions in human keratinocytes (HaCaT cells), considering the beneficial outcomes of this plant in hair loss and wound healing. After preparing the M. communis leaf extract, implementing the phytochemical analysis and determining the non-cytotoxic concentration, we incubated HaCaT cells with the extract. RNA isolations were made from both incubated and unincubated cell groups. Gene expressions were performed by real time RT-qPCR analysis. In phytochemical analysis, M. communis leaf extract was found to contain 1255 ppm total phenolic substance. Results of gene expression analyses were defined as Target/Control Fold Change, and the extract yielded statistically significant downregulation of IL-1α (p = 0.0014) and upregulation of VEGF (p = 0.0021) in the incubated HaCaT cells, compared to unincubated control cells. These preliminary results, which show M. communis leaf extract can modulate the gene expressions of IL-1α and VEGF, may partially be related with the healing effects of this plant for both non-cicatricial hair loss and chronic cutaneous wounds, reported in traditional medicine. Further, in-vitro and in-vivo experiments are needed to understand the mechanisms of the healing effects of M. communis.
Current treatment options for hair loss remain limited. Therefore, this study compared a botanical extract derived from multiple plants with the pharmaceutical agent minoxidil for topical application. The evaluated parameters included inflammatory cytokines (IL-1β, IL-6, TNF-α), growth factors (TGF-β, VEGF, KGF), and 5α-reductase type II (SRD5A2) expression in the human keratinocyte cell line HaCaT, as measured by ELISA. Both the botanical extract and minoxidil reduced IL-6 levels by 21% and 35%, and TNF-α levels by 13% and 35%, respectively. Treatment with the botanical extract and minoxidil increased VEGF expression by 50% and 85%, and KGF by 16% and 31%, respectively, while reducing SRD5A2 expression by 21% and 28%, respectively. Overall, the results of this in vitro study suggest that the botanical extract exhibits a response pattern similar to that of minoxidil, characterized by the suppression of pro-inflammatory cytokines and SRD5A2, along with enhanced expression of growth factors VEGF and KGF in HaCaT cells. These results provide a promising basis for further in vivo studies.
Retinol, a vitamin A derivative belonging to the retinoid family, is widely recognized for its anti-aging and wound-healing properties. In this study, we investigated the effects of retinol on the production of growth factors and major extracellular matrix (ECM) components in human dermal fibroblasts. Cells were treated with 0.05 and 0.5 μM retinol, and the levels of vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), transforming growth factor-beta (TGF-β), hyaluronan synthase-2 (HAS-2), collagen type-I (COL-I), and collagen type-III (COL-III) were quantified using ELISA. Retinol treatment significantly increased the levels of VEGF, FGF-2 and TGF-β at both concentrations tested. Similarly, the levels of the ECM-related markers HAS-2, COL-I and COL-III were elevated following retinol exposure at both concentrations. Collectively, these findings indicate that retinol induces a coordinated pro-regenerative response in human dermal fibroblasts, characterized by enhanced extracellular matrix production, angiogenic signaling, hyaluronic acid synthesis, and tissue remodeling. These results further support the role of retinol as an antiaging and wound healing agent that promotes skin regeneration and maintenance.